Pluristem Therapeutics (PSTI) – Insiders' Blog
-
Pluristem Therapeutics (PSTI) receives FDA orphan status for aplastic anemia treatment
-
Stem Cell Stocks Could See Interest On Obama Lifting Ban On Embryonic Stem Cell Research
-
Stem Cell-Related Stocks on the Move Following Cytori News (CYTX, STEM, PSTI, ASTM)
-
Stem-Cell Stocks Lower on Reports Fetal Cells May Have Triggered Tumors in Sick Boy (STEM, GERN, more)
-
Stem Cell Related Stocks Spiking on Reports Obama to Lift 8-Yr Ban on Embryonic Research (STEM, CYTX, PSTI, ASTM, GERN)
Back to PSTI Stock Lookup